Comment on: "Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively"

被引：1
|
作者：
Ulrich, Sven [1 ]
机构：
[1] Aristo Pharma GmbH, Med Sci Dept, Wallenroder Str 8-10, D-13435 Berlin, Germany
来源：
CNS DRUGS | 2022年 / 36卷 / 01期
关键词：
MELATONIN; PHARMACOLOGY;
D O I：
10.1007/s40263-021-00881-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [1] Comment on: “Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively”
    Sven Ulrich
    CNS Drugs, 2022, 36 : 101 - 102
  • [2] Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively
    Samuel R. Chamberlain
    David S. Baldwin
    CNS Drugs, 2021, 35 : 703 - 716
  • [3] Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively
    Chamberlain, Samuel R.
    Baldwin, David S.
    CNS DRUGS, 2021, 35 (07) : 703 - 716
  • [4] Correction to: Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively
    Samuel R. Chamberlain
    David S. Baldwin
    CNS Drugs, 2022, 36 : 97 - 97
  • [5] Authors' Reply to Ulrich: Comment on `Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use Them Safely and Effectively'
    Baldwin, David S.
    Chamberlain, Samuel R.
    CNS DRUGS, 2022, 36 (01) : 103 - 103
  • [6] Authors’ Reply to Ulrich: Comment on ‘Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use Them Safely and Effectively’
    David S. Baldwin
    Samuel R. Chamberlain
    CNS Drugs, 2022, 36 : 103 - 103
  • [7] Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively (vol 35, pg 703, 2021)
    Chamberlain, Samuel R.
    Baldwin, David S.
    CNS DRUGS, 2022, 36 (01) : 97 - 97
  • [8] REVIEW ON THE USE OF IRREVERSIBLE MONOAMINE-OXIDASE INHIBITORS (MAOIS) IN PSYCHIATRY
    BECHELLI, LP
    NARDI, AE
    ALVES, AB
    CURRENT MEDICAL RESEARCH AND OPINION, 1989, 11 : 38 - 52
  • [9] Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome
    Tort, Sera
    Urrutia, Gerard
    Nishishinya, Maria Betina
    Walitt, Brian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (04):
  • [10] Don’t overlook monoamine oxidase inhibitors in psychiatric practice
    Caroline Fenton
    Arnold Lee
    Drugs & Therapy Perspectives, 2022, 38 : 215 - 220
12345